Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Novel heptacyclic compound and synthesis, activity evaluation and application thereof

A technology of cyclic compounds and drugs, applied in the field of its preparation, can solve problems such as reducing

Active Publication Date: 2017-04-26
CAPITAL UNIVERSITY OF MEDICAL SCIENCES
View PDF1 Cites 23 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, the effective dose of β-carboline, for example, the effective dose of 3S-3-carboxy-1,2,3,4-tetrahydro-β-carboline is as high as 5 μmol / kg, which still needs to be reduced.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Novel heptacyclic compound and synthesis, activity evaluation and application thereof
  • Novel heptacyclic compound and synthesis, activity evaluation and application thereof
  • Novel heptacyclic compound and synthesis, activity evaluation and application thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0019] Example 1 Preparation of 3S-3-carboxy-1,2,3,4-tetrahydro-β-carboline

[0020] To 5.0g (24.5mmol) L-Trp, 25ml H 2 SO 4 Add 8ml formaldehyde (36-38%) to the compound of (1M) and 80ml water. The reaction compound was stirred at room temperature for 2 h, adjusted to pH 7 with concentrated ammonia water, placed at 0°C for 12 h, and the resulting precipitate was filtered out. After recrystallization from acetone, 3.97 g (75%) of the title compound were obtained as colorless crystals. Mp:280-282℃; ESI / MS:217[M+H] + ;IR(KBr):3450,3200,3000,2950,2850,1700,1601,1452,1070,900cm -1 ; 1 HNMR (BHSC-500, DMSO-d6): δ10.99(s, 1H), 9.89(s, 1H), 7.30(t, J=7.5Hz, 1H), 7.22(t, J=8.0Hz, 1H) ,7.01(d,J=8.0Hz,1H),6.81(d,J=7.5Hz,1H),4.01(t,J=4.8Hz,1H),3.75(dd,J=10.5Hz,J=5.0Hz , 1H), 3.64 (dd, J=10.5Hz, J=2.4Hz, 1H), 2.91 (d, J=10.5Hz, 2H), 2.86 (s, 1H).

Embodiment 2

[0021] Embodiment 2 prepares THPDTPI

[0022] Add 0.3mL N -Methylmorpholine to adjust the pH to 9. The reaction mixture was stirred at room temperature for 12 h, TLC (CH 2 Cl 2 / CH 3 OH, 15 / 1) indicated the reaction was complete. The reaction mixture was concentrated under reduced pressure at 45 °C, and the residue was repeatedly triturated with water and acetone, and then purified by silica gel column chromatography (CH 2 Cl 2 / CH 3 OH, 30 / 1), yielding 535 mg (90%) of the title compound as a colorless powder. FT-MS 397.1586[M+H] + . 1 H NMR (800MHz, CDCl 3 ): δ=7.930(s, 2H), 7.448(d, J=8.0Hz, 2H), 7.360(d, J=8.0Hz, 2H), 7.204(t, J=8.0Hz, 2H), 7.124(t ,J=8.0Hz,2H),5.737(d,J=16.0Hz,2H),4.468(dd,J=12.0Hz,J=4.0Hz,2H),4.264(d,J=16.0Hz,2H), 3.535(dd, J=14.4Hz, J=2.4Hz, 2H), 2.927(t, J=13.6Hz, 2H). 13 C NMR (200MHz, CDCl 3 ): δ=169.98, 165.05, 136.71, 136.46, 130.31, 128.40, 126.75, 121.72, 121.60, 119.22, 118.24, 118.15, 111.63, 107.11, 106.01, 57.06, 56.46, 28.06.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a novel heptacyclic compound (2'S,5'S)-tetrahydropyrazine [1',2':1,6] and bis{2,3,4,9-tetrahydro-1H-pyridine [3,4-b] indole}-1',4'-diketone (THPDTPI for short), a preparation method thereof, and antithrombosis action, anti-inflammatory action, anti-tumor action, free radical scavenging action and P-selectin expression inhibition action thereof. Therefore, the invention discloses application of the THPDTPI in preparing a medicament which takes the P-selectin as a target and simultaneously inhibits thrombosis, inflammation and tumor. Because thrombosis and inflammation are the most popular complications in patients with tumor, the THPDTPI not only can treat tumor, but also can prevent patients with tumor from complicating thrombosis and inflammation. The THPDTPI disclosed by the invention has favorable clinical application prospects.

Description

[0001] field of invention [0002] The present invention relates to a novel seven-ring compound (2'S,5'S)-tetrahydropyrazine[1',2':1,6]bis{2,3,4,9-tetrahydro-1H-pyridine[3,4- b] Indole}-1',4'-diketone (abbreviated THPDTPI), relating to its preparation method, relating to its antithrombotic effect, relating to its anti-inflammatory effect, relating to its anti-tumor effect, and further relating to it Free radical scavenging and inhibition of P-selectin expression. Therefore, the present invention relates to the application of THPDTPI in the preparation of drugs targeting P-selectin for inhibiting thrombus, inflammation and tumors. Since thrombus and inflammation are the most common complications of tumor patients, THPDTPI of the present invention can not only treat tumors, but also prevent tumor patients from concurrent thrombosis and inflammation. The THPDTPI of the present invention has a good clinical application prospect. The invention belongs to the field of biomedicine. ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): C07D471/22A61P35/00A61P7/02A61P29/00A61P39/06
CPCC07D471/22
Inventor 赵明彭师奇朱海梅刘佳旺
Owner CAPITAL UNIVERSITY OF MEDICAL SCIENCES
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com